Flora Nasri

8.2k total citations · 3 hit papers
47 papers, 5.2k citations indexed

About

Flora Nasri is a scholar working on Pharmacology, Biological Psychiatry and Experimental and Cognitive Psychology. According to data from OpenAlex, Flora Nasri has authored 47 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 23 papers in Biological Psychiatry and 17 papers in Experimental and Cognitive Psychology. Recurrent topics in Flora Nasri's work include Treatment of Major Depression (25 papers), Tryptophan and brain disorders (23 papers) and Mental Health Research Topics (16 papers). Flora Nasri is often cited by papers focused on Treatment of Major Depression (25 papers), Tryptophan and brain disorders (23 papers) and Mental Health Research Topics (16 papers). Flora Nasri collaborates with scholars based in Canada, Singapore and China. Flora Nasri's co-authors include Roger S. McIntyre, Hartej Gill, Roger Ho, Leanna M.W. Lui, Orly Lipsitz, Amna Majeed, David Chen‐Li, Lee Phan, Jiaqi Xiong and Michelle Iacobucci and has published in prestigious journals such as Neuroscience & Biobehavioral Reviews, Journal of Affective Disorders and Psychopharmacology.

In The Last Decade

Flora Nasri

47 papers receiving 5.1k citations

Hit Papers

Impact of COVID-19 pandemic on mental health in the gener... 2020 2026 2022 2024 2020 2020 2021 1000 2.0k 3.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Flora Nasri Canada 22 3.3k 1.1k 817 798 625 47 5.2k
Orly Lipsitz Canada 20 3.1k 0.9× 928 0.9× 684 0.8× 733 0.9× 434 0.7× 51 4.8k
David Chen‐Li Canada 14 3.0k 0.9× 918 0.8× 678 0.8× 638 0.8× 426 0.7× 23 4.3k
Amna Majeed Canada 15 3.0k 0.9× 1.0k 0.9× 795 1.0× 671 0.8× 586 0.9× 26 4.9k
Lee Phan Canada 15 2.8k 0.9× 908 0.8× 656 0.8× 694 0.9× 407 0.7× 46 4.2k
Michelle Iacobucci Canada 17 2.8k 0.8× 924 0.9× 662 0.8× 740 0.9× 405 0.6× 26 4.4k
Leanna M.W. Lui Canada 31 4.1k 1.3× 1.1k 1.0× 784 1.0× 1.0k 1.3× 514 0.8× 77 7.1k
Søren Dinesen Østergaard Denmark 34 2.4k 0.7× 1.2k 1.1× 1.1k 1.3× 998 1.3× 510 0.8× 200 7.6k
Antonio Ventriglio Italy 31 2.9k 0.9× 1.4k 1.3× 1.1k 1.4× 528 0.7× 441 0.7× 302 5.7k
Konstantinos Ν. Fountoulakis Greece 50 2.6k 0.8× 979 0.9× 1.0k 1.2× 970 1.2× 447 0.7× 303 8.6k
Gabriele Sani Italy 43 3.2k 1.0× 708 0.7× 489 0.6× 795 1.0× 350 0.6× 279 6.9k

Countries citing papers authored by Flora Nasri

Since Specialization
Citations

This map shows the geographic impact of Flora Nasri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flora Nasri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flora Nasri more than expected).

Fields of papers citing papers by Flora Nasri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flora Nasri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flora Nasri. The network helps show where Flora Nasri may publish in the future.

Co-authorship network of co-authors of Flora Nasri

This figure shows the co-authorship network connecting the top 25 collaborators of Flora Nasri. A scholar is included among the top collaborators of Flora Nasri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flora Nasri. Flora Nasri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Yena, Joshua D. Rosenblat, Kayla M. Teopiz, et al.. (2022). A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review. CNS Drugs. 36(10). 1031–1047. 9 indexed citations
2.
Ceban, Felicia, Joshua D. Rosenblat, Kevin Kratiuk, et al.. (2021). Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders. CNS Drugs. 35(9). 925–934. 55 indexed citations
3.
Gill, Hartej, Barjot Gill, Orly Lipsitz, et al.. (2021). The impact of overweight/obesity on monetary reward processing: A systematic review. Journal of Psychiatric Research. 137. 456–464. 16 indexed citations
4.
McIntyre, Roger S., Orly Lipsitz, Leanna M.W. Lui, et al.. (2021). Does pre-treatment functioning influence response to intravenous ketamine in adults with treatment-resistant depression?. Journal of Affective Disorders. 292. 714–719. 5 indexed citations
5.
McIntyre, Roger S., Joshua D. Rosenblat, Nelson B. Rodrigues, et al.. (2021). The effect of intravenous ketamine on cognitive functions in adults with treatment-resistant major depressive or bipolar disorders: Results from the Canadian rapid treatment center of excellence (CRTCE). Psychiatry Research. 302. 113993–113993. 22 indexed citations
7.
Vincenzo, Joshua D. Di, Kayla M. Teopiz, Yena Lee, et al.. (2021). Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effects. Psychiatry Research. 306. 114231–114231. 16 indexed citations
8.
Vincenzo, Joshua D. Di, Orly Lipsitz, Nelson B. Rodrigues, et al.. (2021). Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: Results from the canadian rapid treatment center of excellence. Psychiatry Research. 307. 114321–114321. 8 indexed citations
9.
Lee, Yena, Leanna M.W. Lui, David Chen‐Li, et al.. (2021). Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countries. Journal of Affective Disorders. 290. 364–377. 157 indexed citations breakdown →
10.
McIntyre, Roger S., Orly Lipsitz, Leanna M.W. Lui, et al.. (2021). The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine. Journal of Affective Disorders. 294. 592–596. 11 indexed citations
11.
Alnefeesi, Yazen, Jocelyn K. Tamura, Leanna M.W. Lui, et al.. (2021). Trace amine-associated receptor 1 (TAAR1): Potential application in mood disorders: A systematic review. Neuroscience & Biobehavioral Reviews. 131. 192–210. 23 indexed citations
12.
Park, Caroline, Amna Majeed, Hartej Gill, et al.. (2020). The Effect of Loneliness on Distinct Health Outcomes: A Comprehensive Review and Meta-Analysis. Psychiatry Research. 294. 113514–113514. 290 indexed citations breakdown →
14.
McIntyre, Roger S., Lee Phan, Leanna M.W. Lui, et al.. (2020). Registered clinical trials investigating ketamine for psychiatric disorders. Journal of Psychiatric Research. 127. 1–12. 23 indexed citations
15.
Xiong, Jiaqi, Orly Lipsitz, Flora Nasri, et al.. (2020). Impact of COVID-19 pandemic on mental health in the general population: A systematic review. Journal of Affective Disorders. 277. 55–64. 3542 indexed citations breakdown →
16.
Rodrigues, Nelson B., Roger S. McIntyre, Orly Lipsitz, et al.. (2020). Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence. Expert Opinion on Drug Safety. 19(8). 1031–1040. 34 indexed citations
17.
Lee, Yena, Bing Xiang Yang, Dan Luo, et al.. (2020). Synergistic effect of social media use and psychological distress on depression in China during the COVID‐19 epidemic. Psychiatry and Clinical Neurosciences. 74(10). 552–554. 21 indexed citations
18.
Gill, Hartej, Barjot Gill, David Chen‐Li, et al.. (2020). The emerging role of psilocybin and MDMA in the treatment of mental illness. Expert Review of Neurotherapeutics. 20(12). 1263–1273. 32 indexed citations
19.
Rodrigues, Nelson B., Ashley Siegel, Orly Lipsitz, et al.. (2020). Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation. CNS Spectrums. 27(3). 315–321. 9 indexed citations
20.
McIntyre, Roger S., Mehala Subramaniapillai, Caroline Park, et al.. (2020). The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change. Frontiers in Psychiatry. 11. 546–546. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026